Clinical Laserthermia Systems AB (publ) Cash Flow Reinvestment Rate

Latest as of June 2022: 0.14x

Clinical Laserthermia Systems AB (publ) cash flow reinvestment rate. Clinical Laserthermia Systems AB (publ) (CLS-B) has a Cash Flow Reinvestment Rate of 0.14x as of June 2022, reinvesting Skr95.00K (capex Skr0.00 plus investments Skr-95.00K) from operating cash flow of Skr658.00K. Explore cash flow to debt ratio of Clinical Laserthermia Systems AB (publ) to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.14x
(Capex + Investments) / Operating CF

Total Reinvested

Skr95.00K
Capex + Investments

Operating Cash Flow

Skr658.00K
SEK

Capital Expenditures

Skr0.00
SEK

Clinical Laserthermia Systems AB (publ) Cash Flow Reinvestment Rate by Year (None–None)

Clinical Laserthermia Systems AB (publ) cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Clinical Laserthermia Systems AB (publ). For the full cash flow conversion analysis, see CLS-B cash flow metrics.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow